EyePoint Pharmaceuticals ... (EYPT)
NASDAQ: EYPT
· Real-Time Price · USD
11.09
0.24 (2.21%)
At close: Aug 15, 2025, 3:59 PM
11.09
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT
EyePoint Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.33M | 24.45M | 11.59M | 10.52M | 9.48M | 11.68M | 14.03M | 15.2M | 9.11M | 7.68M | 10.53M | 10.01M | 11.56M | 9.29M | 11.54M | 9.06M | 9.01M | 7.32M |
Cost of Revenue | 165K | 805K | 816K | 736K | 1.4M | 759K | 998K | 1.2M | 1.79M | 640K | 3.41M | 1.41M | 1.73M | 1.78M | 3.03M | 1.82M | 1.93M | 1.39M |
Gross Profit | 5.17M | 23.65M | 10.77M | 9.79M | 8.08M | 10.93M | 13.03M | 14M | 7.31M | 7.04M | 7.12M | 8.61M | 9.83M | 7.52M | 8.51M | 7.23M | 7.08M | 5.93M |
Operating Income | -62.23M | -48.84M | -45.24M | -32.75M | -34.55M | -33.32M | -16.35M | -14.4M | -22.76M | -21.55M | -23.04M | -18.4M | -19.22M | -18.28M | -18.05M | -15.31M | -10.98M | -10.94M |
Interest Income | 2.89M | 3.64M | 3.94M | 3.39M | 3.72M | 4.04M | 2.34M | 1.79M | 1.62M | 1.2M | 1.06M | 640K | 362K | 61K | 6K | 6K | 280K | 1K |
Pretax Income | -59.43M | -45.2M | -41.31M | -29.36M | -30.83M | -29.28M | -14.02M | -12.61M | -22.92M | -21.16M | -43.45M | -18.42M | -19.41M | -20.98M | -19.43M | -16.7M | -10.01M | -12.28M |
Net Income | -59.43M | -45.2M | -41.4M | -29.36M | -30.83M | -29.28M | -14.1M | -12.61M | -22.92M | -21.59M | -64.15M | -18.44M | -19.41M | -22.54M | -19.43M | -16.7M | -10.01M | -12.28M |
Selling & General & Admin | 11.9M | 13.91M | 12.64M | 12.99M | 12.8M | 14.11M | 11.43M | 11.04M | 14.34M | 14.98M | 14.41M | 15.23M | 15.44M | 15.24M | 17.03M | 13.43M | 11.84M | 10.77M |
Research & Development | 55.5M | 58.57M | 43.37M | 29.54M | 29.82M | 30.14M | 17.95M | 17.36M | 15.73M | 13.62M | 15.54M | 11.16M | 12.99M | 9.95M | 8.92M | 8.5M | 5.61M | 5.48M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 205K | 615K | 615K | 615K | 615K | 615K | 615K | 615K |
Operating Expenses | 67.39M | 72.48M | 56.01M | 42.54M | 42.62M | 44.25M | 29.38M | 28.4M | 30.07M | 28.6M | 30.16M | 27M | 29.05M | 25.8M | 26.56M | 22.55M | 18.06M | 16.87M |
Interest Expense | n/a | n/a | 14K | n/a | n/a | n/a | n/a | n/a | 435K | 812K | 781K | 662K | 552K | 1.19M | 1.39M | 1.39M | 1.38M | 1.34M |
Selling & Marketing Expenses | n/a | 35K | 51K | 24K | 50K | 6K | 185K | 479K | 5.29M | 5.74M | 5.92M | 6.02M | 6.88M | 6.69M | 7.81M | 7.37M | 6.66M | 5.66M |
Cost & Expenses | 67.56M | 73.29M | 56.83M | 43.27M | 44.02M | 45.01M | 30.38M | 29.6M | 31.87M | 29.24M | 33.57M | 28.41M | 30.78M | 27.58M | 29.59M | 24.37M | 19.99M | 18.26M |
Income Tax Expense | n/a | n/a | 90K | n/a | n/a | n/a | 83K | n/a | n/a | 422K | 20.7M | 22K | n/a | 1.56M | n/a | 6K | n/a | n/a |
Shares Outstanding (Basic) | 69.93M | 69.77M | 64.56M | 54.45M | 53.21M | 52.91M | 42.17M | 38.34M | 37.58M | 37.49M | 37.35M | 37.34M | 37.32M | 37.25M | 32.7M | 28.77M | 28.6M | 24.73M |
Shares Outstanding (Diluted) | 69.93M | 69.77M | 64.56M | 54.45M | 53.21M | 52.91M | 42.17M | 38.34M | 37.58M | 37.49M | 37.35M | 37.34M | 37.32M | 37.25M | 32.7M | 28.77M | 28.74M | 24.73M |
EPS (Basic) | -0.85 | -0.65 | -0.64 | -0.54 | -0.58 | -0.55 | -0.33 | -0.33 | -0.61 | -0.58 | -1.72 | -0.49 | -0.52 | -0.6 | -0.59 | -0.58 | -0.35 | -0.5 |
EPS (Diluted) | -0.85 | -0.65 | -0.64 | -0.54 | -0.58 | -0.55 | -0.33 | -0.33 | -0.61 | -0.58 | -1.72 | -0.49 | -0.52 | -0.6 | -0.59 | -0.58 | -0.35 | -0.5 |
EBITDA | -59.33M | -48.34M | -40.83M | -28.95M | -30.46M | -28.98M | -13.9M | -12.5M | -22.35M | -20.25M | -42.34M | -17.05M | -18.15M | -19.09M | -17.35M | -14.69M | -7.95M | -10.25M |
EBIT | -59.33M | -48.84M | -41.3M | -29.36M | -30.83M | -29.28M | -14.02M | -12.61M | -22.48M | -20.35M | -42.67M | -17.76M | -18.85M | -19.78M | -18.04M | -15.31M | -8.63M | -10.93M |
Depreciation & Amortization | n/a | 497K | 467K | 408K | 362K | 303K | 112K | 115K | 132K | 105K | 335K | 711K | 704K | 696K | 698K | 615K | 685K | 687K |